NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Share on PinterestRecent research emphasizes the potential role of viral infections and over-the-counter medication in dementia risk. Design by MNT; Photography by alvaro gonzalez/Getty Images, Guido ...

But with 60% of BV cases recurring within a year, women are stuck repeating treatment regimens, upping their risk of antibiotic resistance and yeast infections. A new study in the New England ...

Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus the standard of care treatments Acyclovir and Abreva in a preclinical animal model. Toronto ...

Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus the standard of care treatments Acyclovir and Abreva in a preclinical animal model. Herpes Simplex ...

The herpes simplex virus (HSV) could be sneaking into the brain more often than we're aware. A new study on mice has found that when HSV type 1 infection accesses the body through the nose, it can ...

Professor in Ophthalmology for Research of the Aging Eye ... or ocular infection.” Vaccines, antibiotics, and antivirals may help protect brain health If viruses such as HSV-1 and potentially ...

Additionally, the researchers found that the route of infection, whether through the eye, the nose, or the mouth, significantly impacts a treatment’s effectiveness. The findings are published in ...

The camp, which claimed to offer a solution for hair loss, left participants with pain and redness in the eyes after they applied an oil provided and washed it off later as part of the treatment.

Herpes simplex virus type 1 (HSV-1) is an extremely prevalent virus that’s usually associated with cold sores. The World Health Organization estimates that 64 percent of the global population ...